Society for Endocrinology - a world-leading authority on hormones

New study examines risks and benefits of the first line treatment for diabetes (EurekAlert, 10 April 2012)

11 Apr 2012


A team from France has published a meta-analysis assessing the long-term risk/benefit profile of metformin in PLoS Medicine.

Full article